NPM1 - Biocare Medical
Assessment of Minimal Residual Disease in Standard-Risk AML | NEJM
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias | Haematologica
The NPM1 Mutation Type Has No Impact on Survival in Cytogenetically Normal AML | PLOS ONE
Frontiers | Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AML
Cancers | Free Full-Text | NPM1 Mutational Status Underlines Different Biological Features in Pediatric AML
TRUPCR® NPM1 Qualitative KIT | TRUPCR Europe
Life | Free Full-Text | The Role of Nucleophosmin 1 (NPM1) Mutation in the Diagnosis and Management of Myeloid Neoplasms
NPM1 antibody (ABIN1737584)
JCI - Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates
Knockdown of NPM1 in glioma cells alters nucleolar morphology. ( A ) IF... | Download Scientific Diagram
IJMS | Free Full-Text | Targeting and Monitoring Acute Myeloid Leukaemia with Nucleophosmin-1 (NPM1) Mutation
Self-interaction of NPM1 modulates multiple mechanisms of liquid–liquid phase separation | Nature Communications
Genes | Free Full-Text | Nucleophosmin 1 Mutations in Acute Myeloid Leukemia
Flow cytometric identification of acute myeloid leukemia with limited differentiation and NPM1 type A mutation: a new biologically defined entity | Leukemia
NPM1 Mutant Mediated PML Delocalization and Stabilization Enhances Autophagy and Cell Survival in Leukemic Cells
Anti-Nucleophosmin Monoclonal Antibody(Clone: NPM1/3285)
NPM1 re-distribution serves as a marker for nucleolar stress in glioma... | Download Scientific Diagram
Frontiers | Targeted therapy in NPM1-mutated AML: Knowns and unknowns
Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia | Science
